Atlas Trials

Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients

Clinical trial NCT00857779 · COMPLETED

Trial details

NCT number
NCT00857779
Sponsor
ALK-Abelló A/S
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
RhinitisConjunctivitisAsthma
Start date
2009-02-01
Primary completion
2009-08-01
Enrollment
473

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.